Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=cvmLatest Financial News for CEL-SCI CORPen-usWed, 23 Dec 2009 17:53:10 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12pgosv0o/*http%3A//seekingalpha.com/article/179622-mentor-capital-cancer-vaccine-investing-update?source=yahooyahoo_finance/1110837948Wed, 23 Dec 2009 17:53:10 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12u534s0i/*http%3A//seekingalpha.com/article/177466-all-eyes-on-cel-sci-will-wednesday-s-surge-continue?source=yahooyahoo_finance/564108502Thu, 10 Dec 2009 07:56:36 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12n91bqhd/*http%3A//www.fool.com/investing/options/2009/12/09/a-strategy-for-all-situations.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/1550900973Wed, 9 Dec 2009 21:03:59 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=134lk0p58/*http%3A//www.thestreet.com/_yahoo/story/10638338/1/biotech-stock-mailbag-hemispherx-biopharma.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/83810379Fri, 4 Dec 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091201/ph18742.html?.v=1CEL-SCI Corporation , a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today that it has retained the services of an international Contract Research Organization to run CEL-SCI's upcoming Phase III clinical trial in advanced primary head and neck cancer with the Company's lead product candidate, Multikine®.yahoo_finance/180389866Tue, 1 Dec 2009 15:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12mcn5rp1/*http%3A//seekingalpha.com/article/175277-holiday-cheer-cel-sci-should-have-good-news?source=yahooyahoo_finance/3148615427Wed, 25 Nov 2009 13:06:10 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=138g206tb/*http%3A//www.thestreet.com/_yahoo/story/10631871/1/cel-scis-history-of-disappearing-drugs-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/4040222654Tue, 24 Nov 2009 14:20:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=136vkfovo/*http%3A//www.thestreet.com/_yahoo/story/10631221/1/poniard-finds-cash-to-keep-lights-on-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/682432113Mon, 23 Nov 2009 17:59:22 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13rb52sr2/*http%3A//www.thestreet.com/_yahoo/story/10630997/1/cel-sci-chairman-sells-stock-despite-sweetheart-loan-deal-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/789834026Mon, 23 Nov 2009 15:14:59 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12sarf8s3/*http%3A//www.thestreet.com/_yahoo/story/10629106/1/biotech-stock-mailbag-fda-playbook.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1857405035Fri, 20 Nov 2009 11:01:45 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091118/ph13360.html?.v=1CEL-SCI Corporation , a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today the start of the Company's first clinical study for hospitalized H1N1 patients at The Johns Hopkins University School of Medicine .yahoo_finance/3823378626Wed, 18 Nov 2009 14:45:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13kv67nl0/*http%3A//seekingalpha.com/article/173476-playing-the-options-game-in-rimm-cel-sci-not-yet-trading-to-its-potential?source=yahooyahoo_finance/2556014201Mon, 16 Nov 2009 09:29:10 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12qaie1g4/*http%3A//seekingalpha.com/article/173461-don-t-like-celsius-holdings-try-cel-sci-instead?source=yahooyahoo_finance/3004366082Mon, 16 Nov 2009 07:58:41 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091112/20091112005494.html?.v=1LOS ANGELES----BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, reports that after the market closed on Tuesday, investors of CEL-SCI Corporation learned that the company had filed an "amended" Form S-3 with the SEC.yahoo_finance/1751148693Thu, 12 Nov 2009 12:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13ag771d9/*http%3A//seekingalpha.com/article/172968-why-has-cel-sci-quietly-amended-some-previously-filed-paperwork?source=yahooyahoo_finance/2943489676Thu, 12 Nov 2009 10:21:52 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12rn7b3rs/*http%3A//seekingalpha.com/article/172507-cel-sci-good-news-could-lead-to-long-term-growth?source=yahooyahoo_finance/3671464328Tue, 10 Nov 2009 15:54:44 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091109/ph07441.html?.v=1CEL-SCI Corporation announced today that Dr. Kenneth S. Rosenthal, Professor of Immunology and Microbiology of Northeastern Ohio Universities College of Medicine and Pharmacy, reported on work conducted in collaboration with scientists at the Cleveland Clinic and CEL-SCI on CEL-SCI's LEAPS vaccine technology.yahoo_finance/1247678437Mon, 9 Nov 2009 14:40:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12s8gfsok/*http%3A//www.fool.com/investing/small-cap/2009/11/09/a-big-upgrade-for-rodman-renshaw.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3261567313Mon, 9 Nov 2009 14:00:09 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091109/20091109005769.html?.v=1LOS ANGELES----BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, reports that On Monday and Tuesday of this week, the 7th Annual Vaccines: All Things Considered Conference is taking place in Washington, DC.yahoo_finance/1313817902Mon, 9 Nov 2009 13:26:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12t41mmum/*http%3A//seekingalpha.com/article/172127-d-c-vaccine-conference-investors-should-stay-tuned?source=yahooyahoo_finance/187650053Mon, 9 Nov 2009 08:25:14 Etc/GMT